Piraye Yurttas Beim, PhD

Dr. Piraye Yurttas Beim founded Celmatix in 2009 to empower women to be more proactive and informed about their fertility through better data, including genomics. She was on the front lines of the personalized medicine revolution during her doctoral work at Memorial Sloan Kettering Cancer Center, Weill Cornell (NYC) and was inspired to create the company after completing her postdoctoral embryology research training at the University of Cambridge (UK). Realizing how many of the successful, career-minded women in her network were making major, life-defining decisions around fertility based on age alone, she set out to bring personalized medicine to reproductive health. In addition to her scientific credentials, Dr. Beim has also been widely recognized as an emerging business leader. She is a Fellow of the second class of the Aspen Institute Health Innovators Fellowship program, a member of the Aspen Global Leadership Network, and was named a New York City Venture Fellow by the New York City Economic Development Corporation. She has also been named to Crain’s 40 Under 40, Fortune’s 15 Entrepreneurs Disrupting Your Industry, and TechCrunch’s Top Female Founders. She lives in New York City with her husband and three children.